Tariff Delay Signals Opportunity, Not Crisis, for Generic Pharma: Rohit Aggarwal

By:-Rohit Aggarwal, Founder & CIO of Ro Fund Management,

“We think the market’s negative reaction is overdone, and in fact, think it’s positive news, We now have clarity for the next two years that there are no tariffs. This is simply a pressure tactic to get US companies to shift some manufacturing back to the US an unrealistic dream given the massive differential in costs to manufacture in low-cost countries.”

Leave a Reply

Your email address will not be published. Required fields are marked *